Showing 6,001 - 6,020 results of 6,705 for search '"Germany"', query time: 0.09s Refine Results
  1. 6001
  2. 6002
  3. 6003
  4. 6004
  5. 6005
  6. 6006

    Immune status improvement in piglets through the use of interferon-containing products during specific prevention of porcine pleuropneumonia by A. G. Shakhov, L. Yu. Sashnina, V. A. Prokulevich, Yu. Yu. Vladimirova, M. I. Adodina

    Published 2021-08-01
    “…Tests were carried out in clinically healthy 30–35-day-old piglets immunized with Ingelvac® APPX vaccine (Boehringer Ingelheim Vetmedica GmbH, Germany). It was found that the use of biferon-S and prostimul together with the vaccine administration is accompanied by immune status improvement in the animals, which is manifested as an increase, in comparison with vaccinated animals that received no interferon-containing products (base case), in serum levels of γ-globulins – by 34.6 and 53.7% (in case of prostimul and β-globulins – by 10.1%), total immunoglobulins – by 32.8 and 37.8%, large circulating immune complexes – by 37.5 and 52.6%, a less significant increase in the levels of small complexes and, as a result, pathogenicity coefficient reduction by 5.4 and 12.4%, respectively. …”
    Get full text
    Article
  7. 6007
  8. 6008
  9. 6009
  10. 6010

    Shaping Ability of Reciproc, UnicOne, and Protaper Universal in Simulated Root Canals by Etevaldo Matos Maia Filho, Cláudia de Castro Rizzi, Matheus Bandeca Coelho, Sara Freitas Santos, Luzia Mayanne Oliveira Costa, Ceci Nunes Carvalho, Rudys Rodolfo de Jesus Tavarez, Janir Alves Soares

    Published 2015-01-01
    “…The study aimed to compare the shaping effects, preservation of the original curvature, and transportation of the apical foramen of Reciproc (VDW, Munich, Germany), UnicOne (Medin, Nové Město na Moravě, Czech Republic), and Protaper Universal (Dentsply Maillefer, Ballaigues, Switzerland) in simulated root canals. …”
    Get full text
    Article
  11. 6011
  12. 6012
  13. 6013
  14. 6014

    Rationale and design of the multicenter, national, randomized, open labeled phase III trial: allogeneic stem cell transplantation as a potential curative treatment for patients wit... by Annemarie Glöckner, Stefan Schönland, Hermann Einsele, Nicolaus Kröger

    Published 2025-01-01
    “…Methods This clinical trial is a national, multicenter, randomized, open labeled phase III study conducted in 30 hospitals spread all over Germany. After study inclusion, all patients will receive 3 cycles of salvage therapy with one of the currently approved triplet regimens for first relapse. …”
    Get full text
    Article
  15. 6015
  16. 6016
  17. 6017
  18. 6018
  19. 6019
  20. 6020

    The economic burden of Lyme disease and the cost-effectiveness of Lyme disease interventions: A scoping review. by Stephen Mac, Sara R da Silva, Beate Sander

    Published 2019-01-01
    “…Six studies assessed economic burden from a societal perspective and estimated significant annual national economic impact of: 735,550 USD for Scotland (0.14 USD per capita, population = 5.40M), 142,562 USD in Sweden (0.014 USD per capita, 9.96M), 40.88M USD in Germany (0.51 USD per capita, 80.59M), 23.12M USD in the Netherlands (1.36 USD per capita, 17.08M), and up to 786M USD in the US (2.41 USD per capita, 326.63M).…”
    Get full text
    Article